Print this article
- 10/28/2019

Meet Dr. Reddy’s Custom Pharma Services at CPhI Worldwide! Celebrating two decades of successful service partnerships

Chimica Oggi-Chemistry Today

Dr. Reddy’s Custom Pharma Services (CPS) is Dr. Reddy’s fully integrated CDMO (Custom Development and Manufacturing Organization) and recognized as a preferred service partner for global pharma companies. Over the last two decades, CPS has earned an impeccable track record in project delivery on time and on budget. With a strong presence in the USA, Europe and Asia Pacific, CPS serves as an extended team for its global customers. Its full service offering includes but is not limited to discovery, preclinical services, route scouting, intermediates, APIs, clinical phase appropriate formulations, registration batches, validation and commercial GMP manufacturing.

Small molecules, peptides, chiral chemistry, high potent molecules, steroids, activated mPEGs and various formulation technologies are serviced from CPS R&D center in India. This R&D center is US FDA inspected site, ISO270001 Information Security Management System (ISMS) certified, electronic note book (ELN) enabled and houses multidisciplinary teams of medicinal chemistry, DMPK, in vitro and in vivo pharmacology, biology, biochemistry, process development, formulation development, regulatory affairs, development quality assurance teams and QbD experts.

Leveraging Dr. Reddy’s vast experience in the pharmaceutical industry and its network of 20+ cGMP manufacturing sites, CPS can offer seamless scale-up from mg to commercial scale. Diligent health, environment and safety standards contribute to our customers’ sustainable supply chain performance. CPS’ regulatory affairs team has in-depth experience and understanding of the regulatory requirements in various countries and works closely with our customers to accelerate time to market. They works closely with customers to accelerate product filings and approvals. Owning the Intellectual Property (IP) is a critical for most of our partners, especially small drug development companies/biotechs. CPS’s IP model makes it possible to create and add value to our customer’s technical assets by developing patentable technologies/routes/processes that are exclusively retained by the customer.

Get in touch with us, or meet us during CPhI Worldwide to learn more on how CPS can seamlessly support you from innovation to commercialization of your API and drug product. Our team looks forward to meeting you at booth 80F31 in hall 8.

Visit www.drreddys-cps.com

Email ContactCPS@drreddys.com